Storage and disposal of medical cannabis among patients with cancer: Assessing the risk of diversion and unintentional digestion

Cancer

Volumn 122, Issue 21, 2016, Pages 3363-3370

  Sznitman, Sharon R ^a   Goldberg, Victoria ^b   Sheinman Yuffe, Hedva ^b   Flechter, Ezequiel ^b   Bar Sela, Gil ^b,c  

^a UNIVERSITY OF HAIFA   (Israel)

^b Division of Oncology   (Israel)

^c TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

disposal; diversion; medical cannabis; oncology patients; storage; unintentional digestion

Indexed keywords

MEDICAL CANNABIS;

ADULT; ARTICLE; CANCER PATIENT; CAREGIVER; DRUG STORAGE; DRUG USE; FEMALE; HEALTH BEHAVIOR; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; PRESCRIPTION DRUG DIVERSION; PRIORITY JOURNAL; SAFETY; THEFT; UNINTENTIONAL DIGESTION; WASTE DISPOSAL; DIGESTION; FOLLOW UP; METHODOLOGY; MIDDLE AGED; NEOPLASMS; PATHOLOGY; PROGNOSIS; RISK ASSESSMENT; STANDARDS; SURVIVAL RATE;

CAREGIVERS; DIGESTION; DRUG STORAGE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MEDICAL MARIJUANA; MIDDLE AGED; NEOPLASMS; PRESCRIPTION DRUG DIVERSION; PROGNOSIS; REFUSE DISPOSAL; RESEARCH DESIGN; RISK ASSESSMENT; SURVIVAL RATE;

EID: 84991677885     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.30185     Document Type: Article

References (36)

1. United Nations Office on Drugs and Crime. World Drug Report. New York: United Nations; 2015.
2. Volkow ND, Baler RD, Compton WM, Weiss SR. Adverse health effects of marijuana use. N Engl J Med. 2014;370:2219–2227.
3. Hall W, Degenhardt L. The adverse health effects of chronic cannabis use. Drug Test Anal. 2014;6:39–45.
4. Hall W. What has research over the past two decades revealed about the adverse health effects of recreational cannabis use? Addiction. 2015;110:19–35.
5. Gilman JM, Kuster JK, Lee S, et al. Cannabis use is quantitatively associated with nucleus accumbens and amygdala abnormalities in young adult recreational users. J Neurosci. 2014;34:5529–5538.
6. Wilkinson ST, D'Souza DC. Problems with the medicalization of marijuana. JAMA. 2014;311:2377–2378.
7. Parmar JR, Forrest BD, Freeman RA. Medical marijuana patient counseling points for health care professionals based on trends in the medical uses, efficacy, and adverse effects of cannabis-based pharmaceutical drugs. Res Social Adm Pharm. 2016;12:638–654.
8. Wilkie G, Sakr B, Rizack T. Medical marijuana use in oncology: a review [published online ahead of print March 17, 2016]. JAMA Oncol. doi: 10.1001/jamaoncol.2016.0155.
9. Bar-Sela G, Vorobeichik M, Drawsheh S, Omer A, Goldberg V, Muller E. The medical necessity for medicinal cannabis: prospective, observational study evaluating the treatment in cancer patients on supportive or palliative care. Evid Based Complement Alternat Med. 2013;2013:510392.
10. Waissengrin B, Urban D, Leshem Y, Garty M, Wolf I. Patterns of use of medical cannabis among Israeli cancer patients: a single institution experience. J Pain Symptom Manage. 2015;49:223–230.
11. Machado Rocha FC, Stefano SC, De Cassia Haiek R, Rosa Oliveira LM, Da Silveira DX. Therapeutic use of cannabis sativa on chemotherapy-induced nausea and vomiting among cancer patients: systematic review and meta-analysis. Eur J Cancer Care (Engl). 2008;17:431–443.
12. National Conference of State Legislatures. State Medical Marijuana Laws. Washington, DC: National Conference of State Legislatures; 2013.
13. Belle-Isle L, Walsh Z, Callaway R, et al. Barriers to access for Canadians who use cannabis for therapeutic purposes. Int J Drug Policy. 2014;25:691–699.
14. Nathan G. Promoting the Regulation of the Use of Medical Cannabis in Israel. Jerusalem, Israel: Israeli Knesset's Center for Research and Information; 2012.
15. Landschaft Y. Cannabis for treatment and research-regulatory procedure in Israel. In: Cannabis-Based Drug Development, New Frontiers in Weed Medicine. Jerusalem, Israel 2015. Conference was March 25, 2015.
16. Sznitman S, Lewis N. Is cannabis an illicit drug or a medicine? A quantitative framing analysis of Israeli newspaper coverage. Int J Drug Policy. 2015;26:446–452.
17. Inciardi JA, Surratt HL, Kurtz SP, Cicero TJ. Mechanisms of prescription drug diversion among drug-involved club- and street-based populations. Pain Med. 2007;8:171–183.
18. Salomonsen-Sautel S, Sakai JT, Thurstone C, Corley R, Hopfer C. Medical marijuana use among adolescents in substance abuse treatment. J Am Acad Child Adolesc Psychiatry. 2012;51:694–702.
19. Thurstone C, Lieberman SA, Schmiege SJ. Medical marijuana diversion and associated problems in adolescent substance treatment. Drug Alcohol Depend. 2011;118:489–492.
20. Wang GS. Pediatric concerns due to expanded cannabis use: unintended consequences of legalization [published online ahead of print May 2, 2016]. J Med Toxicol.
21. Watson WA, Litovitz TL, Klein-Schwartz W, et al. 2003 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med. 2004;22:335–404.
22. Wang GS, Roosevelt G, Heard K. Pediatric marijuana exposures in a medical marijuana state. JAMA Pediatr. 2013;167:630–633.
23. Wang GS, Roosevelt G, Le Lait MC, et al. Association of unintentional pediatric exposures with decriminalization of marijuana in the United States. Ann Emerg Med. 2014;63:684–689.
24. Kim HS, Monte AA. Colorado cannabis legalization and its effect on emergency care [published online ahead of print February 24, 2016]. Ann Emerg Med. doi: 10.1016/j.annemergmed.2016.01.004.
25. De Bolle L, Mehuys E, Adriaens E, Remon JP, Van Bortel L, Christiaens T. Home medication cabinets and self-medication: a source of potential health threats? Ann Pharmacother. 2008;42:572–579.
26. Kardas P, Pechere JC, Hughes DA, Cornaglia G. A global survey of antibiotic leftovers in the outpatient setting. Int J Antimicrob Agents. 2007;30:530–536.
27. Grigoryan L, Haaijer-Ruskamp FM, Burgerhof JG, et al. Self-medication with antimicrobial drugs in Europe. Emerg Infect Dis. 2006;12:452–459.
28. Tanabe P, Paice JA, Stancati J, Fleming M. How do emergency department patients store and dispose of opioids after discharge? A pilot study. J Emerg Nurs. 2012;38:273–279.
29. SPSS Inc. SPSS Base 19.0 for Windows User's Guide. Chicago, IL: SPSS Inc; 2010.
30. Connecticut General Assembly. Palliative Use of Marijuana. House Bill 5389, Chapter 420F. https://www.cga.ct.gov/2012/act/pa/pdf/2012PA-00055-R00HB-05389-PA.pdf. Accessed June 26, 2016.
31. Linares R, Choi-Nurvitadhi J, Cooper S, Ham Y, Ishmael JE, Zweber A. Personnel training and patient education in medical marijuana dispensaries in Oregon. J Am Pharm Assoc (2003). 2016;56:270–273.e2.
32. Sznitman SR. Cannabis treatment in Europe: a review. In: Sznitman SR, Room R, Olsson B, eds. A Cannabis Reader: Global Issues and Local Experiences. Lisbon, Portugal: European Monitoring Centre for Drugs and Drug Addiction; 2008:282–295. EMCDDA Monograph Series 8.
33. Rush B, Urbanoski K. Estimating the demand for treatment for cannabis-related problems in Canada. Int J Ment Health Addict. 2007;5:181–186.
34. Urbanoski KA, Strike CJ, Rush BR. Individuals seeking treatment for cannabis-related problems in Ontario: demographic and treatment profile. Eur Addict Res. 2005;11:115–123.
35. Roxburgh A, Hall WD, Degenhardt L, et al. The epidemiology of cannabis use and cannabis-related harm in Australia 1993-2007. Addiction. 2010;105:1071–1079.
36. European Monitoring Centre for Drugs and Drug Addiction. European Drug Report: Trends and Developments. Lisbon, Portugal: European Monitoring Centre for Drugs and Drug Addiction; 2015.